EVOLUTION OF INDICATIONS AND UP-TO-DATE CONCEPT OF APPROPRIATE SELECTION OF CANDIDATES FOR CARDIAC RESYNCHRONIZATION THERAPY
Abstract
About the Authors
A. Sh. RevishviliRussian Federation
N. M. Neminushchy
Russian Federation
References
1. Wiggers C.J. The muscular reactions of the mammalian ventricles to artificial surface stimuli. Am J Physiol 1925; 73: 346-78.
2. Vagnini FJ., Gourin A., Antell H.I. et al. Implantation sites of cardiac pacemaker electrodes and myocardial contractility. Ann Thorac Surg 1967; 4: 431-439.
3. Tyers G.F. Comparison of the effect on cardiac function of single-site and simultaneous multiple-site ventricular stimulation after A-V block. J Thorac Cardiovasc Surg 1970; 59: 211-217.
4. Gibson D.G., Chamberlain D.A., Coltart D.J. et al. Effect of changes in ventricular activation on cardiac haemodynamics in man. Comparison of right ventricular, left ventricular, and simultaneous pacing of both ventricles. Br Heart J 1971; 33: 397-400.
5. De Teresa E., Chamoro J.L., Pupon A. An even more physiological pacing: changing the sequence of ventricular activation. In: Steinbach E., ed. Proceedings of the VIIth World Congress on Cardiac Pacing, Vienna, Austria; 1983. p95-100.
6. Grines C.L., Bashore T.M., Boudoulas H. et al., Functional Abnormalities in Isolated Left Bundle Branch Block; The Effect of Interventricular Asynchrony, Circulation 1989; 79: 845-853.
7. Gottipaty V.K., Krelis S.P., Lu F. et al. The resting electrocardiogram provides a sensitive and inexpensive marker of prognosis in patients with chronic congestive heart failure. J Am Coll Cardiol 1999; 33(Suppl. A): 145A.
8. Baldasseroni S., Opasich C., Gorini M. et al. Italian Network on Congestive Heart Failure Investigators. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002; 143: 398405.
9. Iuliano S., Fisher S.G., Karasik P.E. et al. Department of Veterans Affair Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002; 143: 1085-91.
10. Cazeau S., Ritter P., Bakdach S. et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994; 17: 1974-197.
11. Daubert J.C., Ritter P., Le Breton H., et al. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. PACE. - 1998. Vol. 21. P. 239-245.
12. Blanc J.J., Etienne Y., Gillard M., Mansourati J., Munier S., Boschat J., Benditt D.G., Lurie K.G. Evaluation of different ventricular pacing sites in patients with severe heart failure Circulation. - 1997. - Vol. 96. - P. 3273-3277.
13. Auriccio A., Salo R. Acute hemodynamic improvement by pacing in patients with severe congestive heart failure // PACE. - 1997. - Vol. 20. - P. 313-324.
14. Kass D.A., Chen C.H., Curry C. et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay // Circulation. - 1999. - Vol. 99. - P. 1567-1573.
15. Leclercq C., Cazeau S., Le Breton H. et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure // J. Am. Coll. Cardiol. - 1998. - Vol. 32. - P. 1825-1831.
16. Kim W.Y., Sogaard P., Mortensen P.T. et al. Three dimensional echocardiography documents haemodynamic improvement by biventricular pacing in patients with severe heart failure // Heart. - 2001. Vol. 85. P. 514-520.
17. Jais P., Shah D.C., Takahashi A. et al. Endocardial biventricular pacing // Eur. Heart. J. - 2000. - Vol. 21. - P. 192A.
18. Reuter S., Garrigue S., Bordachar P. et al. Intermediate-term results of biventricular pacing in heart failure: Correlation between clinical and hemodynamic data // PACE. - 2000. Vol. 23. - P. 1713-1717.
19. Yu C.M., Chau E., Sanderson J.E. et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation. 2002; V. 105.Р. 438-445.
20. Auricchio A., Stellbrink C., Sack S., et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. (PATH-CHF, 2002). J Am Coll Cardiol 2002; 39: 2026-33.
21. Butter C., Auricchio A., Stellbrink C. et al. Effect of Resynchronization Therapy Stimulation Site on the Systolic Function of Heart Failure Patients (PATH-CHF-II). Circulation. 2001; 104: 3026-3029.
22. Cazeau S., Leclercq C., Lavergne T. et al. Multisite Stimulation in Cardiomyopathies (MUSTIC SR) Study Investigators: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med. 2001; Vol. 344. P. 873-880.
23. Leclercq C., Walker S., Linde C., et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation.( MUSTIC AF, 2002). Eur Heart J 2002; 23: 1780-1787.
24. Abraham W.T., Fisher W.G., Smith A.L. et al. for the MIRACLE Study Group. Cardiac Resynchronization in Chronic Heart Failure. N. Engl. J. Med. 2002; Vol. 346. - P. 1845-1853.
25. Cleland J.G.F., Daubert J.C., Erdmann E. et al. The CARE-HF study (Cardiac Resynchronisation in Heart Failure study): rationale, design and end-points. Eur. J. Heart Fail. 2001; Vol. 3. - Р. 481-489.
26. Cleland J.G.F., Daubert J.C., Erdmann E. et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. (CARE-HF) N. Engl. J. Med. 2005. - Vol. 352. - Р. 1539-1549.
27. Cleland J.G.F., Daubert J.C., Erdmann E. et al. Longterm effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur. Heart J. 2006. - Vol.27. - Р.1928-1932.
28. Doshi R.N., Daoud E.G., Fellows C., et al. Left Ventricular-Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (the PAVE study). J Cardiovasc Electrophysiol. 2005; 16: 1160-1165.
29. Eldadah Z.A., Strickberger S.A. PAVEing the way for cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2005; 16: 1166-1167.
30. Young J.B., Abraham W.T., Smith A.L. et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003; 289: 2685-94.
31. Abraham W.T., Young J.B., Len A.R. Et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. MIRACLE-ICD-II, 2004. Circulation 2004; 110: 2864-2868.
32. Higgins S.L., Hummel J.D., Niazi I.K. Et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. CONTAK-CD. J Am Coll Cardiol. 2003 Oct 15; 42(8): 1454-1459.
33. Bristow M.R., Saxon L.A., Boehmer J. et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 2004; Vol. 350. - Р. 2140-2150.
34. Carson P., Anand I., O’Connor C. et al. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial // J. Am. Coll. Cardiol. - 2005. - Vol.46, № 12. - Р. 2329 -2334.
35. Hunt S.A., Abraham W.T., Chin M.H. et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult - Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J. Am. Coll. Cardiol. 2005. Vol. 46: 116-1143.
36. Zipes D., Camm A.J., Borggrefe M. et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death - Executive Summary. Eur. Heart J. 2006; 27: 2099-2140.
37. Swedberg K., Cleland J., Dargie H. et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology Eur. Heart J.2005. Vol. 26: 1115-1140
38. Hunt S.A., Abraham W.T., Chin M.H. et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult - Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J. Am. Coll. Cardiol. 2005. Vol. 46: 116-1143
39. Zipes D., Camm A.J., Borggrefe M. et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death - Executive Summary. Eur. Heart J. 2006; 27: 2099-2140.
40. Swedberg K., Cleland J., Dargie H. et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology Eur. Heart J.2005. Vol. 26: 1115-1140.
41. Рекомендации Всероссийского научного общества специалистов по клинической электрофизиологии, аритмологии и кардиостимуляции по проведению клинических электрофизиологических исследований, катетерной абляции и имплантации антиаритмических устройств. - Москва, 2005, 238 с.
42. Беленков Ю.Н., Васюк Ю.А., Галявич А.С. и соавт. Национальные Рекомендации ВНОК И ОССН по диагностике и лечению ХСН (второй пересмотр). Сердечная Недостаточность - 2007, № 1; 3: 62.
43. Moss A.J., Hall W.J., Cannom D.S. et al. Cardiac-Resynchronization therapy for the prevention of heart-failure events. N. Engl. J. Med. 2009; 361: 1329-1338.
44. Daubert J.C., Gold M.R., Abraham W.T. et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J. Am. Coll. Cardiol. 2009; 54: 1837-1846.
45. Tang A.S., Wells G.A., Talajic M. et al. Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure. N. Engl. J Med. 2010; 363: 2385-95.
46. Dickstein K., Vardas P.E., Auricchio A. et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure. An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Eur. Heart J. 2010; 31: 2677-2687.
47. Moss A.J., Zareba W., Hall W.J. et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Eng. J. Med. 2002; 346: 877-883.
48. Bardy G.H., Lee K.L., Mark D.B. et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 2005; 352: 225-237.
49. Haghjoo M., Bagherzadeh A., Fazelifar A.F. et al. Prevalence of Mechanical Dyssynchrony in Heart Failure Patients with Different QRS Durations. PACE. 2007; 30: 616-622.
50. Bax J.J., Abraham T., Barold S.S., Breithardt O.A. et al. Cardiac resynchronization therapy: Part 1. Issues before device implantation. J Am Coll Cardiol 2005; 46: 2153 -2167.
51. Haghjoo M., Bagherzadeh A., Farahani M.M. et al. Significance of QRS morphology in determining the prevalence of mechanical dyssynchrony in heart failure patients eligible for cardiac resynchronization: particular focus on patients with right bundle branch block with and without coexistent left-sided conduction defects. Europace. 2008; 10: 566-571.
52. Rickard J., Kumbhani D.J., Gorodeski E.Z. et al. Cardiac resynchronization therapy in non-left bundle branch block morphologies. Pacing. Clin. Electrophysiol. 2010; 33(5): 590-595.
53. Rickard J., Bassiouny M., Cronin E.M., et al. Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology. Am J Cardiol. 2011; 108: 1576-1580.
54. Zareba W., Klein H., Cygankiewicz I., et al. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial - Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011; 123: 1061-1072.
55. McMurray J., Adamopoulos S., Anker S., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur. Heart J. 2012; 33: 17871847.
56. Brignole M., Auricchio A., Baron-Esquivias G., et al. 2013 ESC Guidelines on Cadiac Pacing and Cardiac Resynchronization Therapy. European Heart Journal 2013; 34: 2281-2329.
57. Ypenburg C., Van Bommel R.J., Borleffs W. Long-Term Prognosis After Cardiac Resynchronization Therapy Is Related to the Extent of Left Ventricular Reverse Remodeling at Midterm Follow-Up. J Am Coll Cardiol. 2009; 53(6): 483-490.
58. Saba S., Marek J., Schwartzman D. et al. Echocardiography-Guided Left Ventricular Lead Placement for Cardiac Resynchronization Therapy. Circ Heart Fail. 2013; 6: 427 -434.
59. Khan F.Z., Virdee M.S., Palmer C.R. et al. Targeted Left Ventricular Lead Placement to Guide Cardiac Resynchronization Therapy. J Am Coll Cardiol 2012; 59: 1509-1518.
60. Ploux S., Lumens J., Whinnett Z. et al., Noninvasive Electrocardiographic Mapping to Improve Patient Selection for Cardiac Resynchronization Therapy. J Am Coll Cardiol 2013; 61: 2435-2443.
Review
For citations:
Revishvili A.Sh., Neminushchy N.M. EVOLUTION OF INDICATIONS AND UP-TO-DATE CONCEPT OF APPROPRIATE SELECTION OF CANDIDATES FOR CARDIAC RESYNCHRONIZATION THERAPY. Journal of Arrhythmology. 2014;(76):41-50. (In Russ.)